References
- Hugenard J. Block of T-type Ca + 2 channels is an important action of succinimide antiabsence drugs. Epilepsy Curr. 2002;2(2):49–52.
- Kim P, Westover R, Shulman J. Case report: ethosuximide overdose. Clin Toxicol. 2020;58(11):1158. [abstract]
- Ethosuximide [package insert]. New York (NY): Pfizer, Inc.; 2010.
- Battino D, Estienne M, Avanzini G. Clinical pharmacokinetics of antiepileptic drugs in pediatric patients. Part I: phenobarbital, primidone, valproic acid, ethosuximide and mesuximide. Clin Pharmacokinet. 1995;29(4):257–286.
- Patsalos PN, Zugman M, Lake C, et al. Serum protein binding of 25 antiepileptic drugs in a routine clinical setting: a comparison of free non-protein-bound concentrations. Epilepsia. 2017;58(7):1234–1243.
- Marbury T, Lee C, Perchalski R, et al. Hemodialysis clearance of ethosuximide in patients with chronic renal disease. Am J Hosp Pharm. 1981;38(11):1757–1760.